FdaApplication
ANDA 206039
Identifiers
- fda_app_no: ANDA206039
Properties
| Property | Value |
|---|---|
| applicant_name | EXELA PHARMA SCIENCES LLC |
| application_type | ANDA |
| approval_date | 2014-12-18 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MAGNESIUM SULFATE | MAGNESIUM SULFATE | 5GM/10ML (500MG/ML) | SOLUTION;INTRAMUSCULAR, INTRAVENOUS |
1 product